Risk Factors
424 articles
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
Integrative Oncology Explained
Dr. Santosh Rao believes in the value of integrative oncology, which treats the whole person, not just the patient.
Hope is Everything You Have
Long-term survivor Eric Borden believes in the importance of advocating for yourself with your doctors; if he hadn’t he might not be here.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
Listen to the Patient
Long-term survivor Michael Whalen is here because he pushed his doctors to follow up on his concern about possibly having pancreatic cancer.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
All About End-of-Life Planning: Difficult Conversations
Do you know how to prepare for end-of-life? Do you want to make it easier on your family? Dr. Dawn Gross provides some planning guidelines.
Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer
In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Embrace All the Good Things
After two bouts with pancreatic cancer, long-term survivor Anthony Del Russo embraces all the good in life with his family and friends.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
Appreciation for Humanity
Dr. Errol D. Toulon, Jr., is an example of resiliency, as a long-term survivor of pancreatic cancer and Hodgkin’s lymphoma.
Let’s Win Pancreatic Cancer Survivors Series—Year Seven
Our Survivors Video Series is entering Year Seven with even more inspiring stories of taking on pancreatic cancer and life.
Steely Strength to Keep Going
Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.